Lung cancer
Advancing care,
one breath at a time
Pfizer is working to transform lung cancer treatment. We also help empower patients and their caregivers throughout their journeys with lung cancer.
Lung cancer survival rates are improving, but more work is needed
About 1 in 5 cancer deaths in the US is due to lung cancer. It is by far the nation’s deadliest cancer. And yet, lung cancer death rates have been going down since the early 2000s. Advances in research and earlier detection have helped improve lung cancer survival rates.
- #1
cause of cancer-related deaths in the US in 2025 - 86%
of lung cancers in the US are caused by smoking - 226,650
new cases of lung cancer are estimated to be diagnosed in the US in 2025 - 50%
relative increase in early stage diagnosis since screening was recommended in 2013
Transforming lung
cancer care
Pfizer has led the way in developing medicines targeting certain biomarkers in lung cancer. We’re continuing to work to change lung cancer care by researching new ways to approach the disease.
Know the risks, symptoms, and treatment options
Who is at risk for lung cancer?
Learn about the factors that can increase your risk of developing lung cancer and how to reduce them.
Know the symptoms of lung cancer
Find out what the symptoms of lung cancer are and what you should do if you or loved ones have any.
How biomarkers can unlock information
Biomarkers can help care teams identify treatment options shown to be effective in lung cancer subtypes.
A focus on improving health equity
We’re working to overcome health disparities in lung cancer
Asians and Pacific Islanders with lung cancer were 17% less likely to be diagnosed early compared to White people
Latinx people with lung cancer are 30% more likely to not receive any treatment compared to White people
Black people with lung cancer are 16% less likely to survive 5 years compared to White people
Sharing strength & support
For Bill, self-advocacy was essential in uncovering and managing his lung cancer diagnosis. With the unwavering support of his wife and caregiver, Connie, he’s remained active throughout his cancer journey.
Resources & community
LUNGevity Foundation
Transforming how people are diagnosed and live with lung cancer through research, education, and support.
GO2 for Lung Cancer
Dedicated to increasing survival and quality of life for people at risk, diagnosed, and living with lung cancer.
Lung Cancer Research Foundation
Dedicated to funding research for the prevention, diagnosis, treatment, and cure of lung cancer.